Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Gonda, K.
Right arrow Articles by Takenosita, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonda, K.
Right arrow Articles by Takenosita, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 32:215-218 (2002)
© 2002 Foundation for Promotion of Cancer Research

A Novel Germline Mutation of hMLH1 in a Patient with Hereditary Non-polyposis Colorectal Cancer

Kenji Gonda1, Tadashi Nomizu1, Noriko Fukayama2, Kokichi Sugano2 and Seiichi Takenosita3,+

1 Department of Surgery, Hoshi General Hospital, Fukushima, 2 Oncogene Research Unit/Cancer Prevention Unit, Tochigi Cancer Center Research Institute, Utsonomiya and 3 Department of Second Surgery, Fukushima Medical University, School of Medicine, Fukushima, Japan

DNA mismatch repair genes, hMLH1 and hMSH2, assigned on chromosome 3p21–23 and 2p21–22 are involved in hereditary non-polyposis colorectal cancer (HNPCC). The heterozygous carrier of the mutated allele results in a mutator phenotype and accelerating tumorigenesis, which especially causes carcinomas in the gastrointestinal and genitourinary tracts. We screened germline mutations of mismatch repair genes hMLH1 and hMSH2 in a patient with multiple primary neoplasms (multiple stomach cancers, colon cancer and brain tumor) in a cancer clustered HNPCC family. Screening by long RT-PCR from the RNA extracted from puromycin-treated heparinized blood showed skipping of the exon 2 in hMLH1. The analysis of the genomic DNA showed a GT deletion in the splice-donor site of the exon 2, which is compatible with the splicing variant detected by long RT-PCR analysis. This is a novel germline mutation that has not been reported previously.

+ For reprints and correspondence: Kenji Gonda, Department of Surgery, Hoshi General Hospital, Omathi 2–1–16, Koriyama, Fukushima 963-8501, Japan. E-mail: nomizu@hoshipital.or.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.